Kenalog 10 for Injection contains the active ingredient triamcinolone acetonide, which is a synthetic corticosteroid. It is used to treat a variety of conditions, including allergies, arthritis, hormonal disorders, skin problems, and certain types of cancer. Specifically, it may be used to help reduce inflammation and swelling in the body, relieve pain, and suppress the immune system. It may also be used for diagnostic purposes in certain medical procedures. It is only available through a prescription and should be used under the guidance of a healthcare provider.
Kenalog 10 Injection (triamcinolone acetonide) is a steroid injected into the joint space to treat inflammation of the joints or tendons to treat arthritis, bursitis, or epicondylitis (tennis elbow). Kenalog 10 is usually given in these conditions as a short-term treatment of a severe or aggravated episode.
Benefits of Kenalog 10 mg for Injection
- Provides relief from severe, chronic or acute inflammation without long-term changes to physiological systems
- Can be used to objectively evaluate individual responses to intra-articular injections
- Fast-acting and effective treatment for allergies, rashes, eczema, hives and psoriasis
- An ideal option when traditional oral medications are not tolerated
- Ibuprofen and other pain relief medications do not need to be used simultaneously for effective pain relief
- Reduced risk of side effects when compared to other anti-inflammatory drugs
- Provides relief from severe joint or musculoskeletal pain
- Can help improve mobility and range of motion  Â
- Reduction of stiffness in joint pain and muscle pain
- Corticosteroid formulation with minimal risk of systemic absorptionÂ
Brand: Bristol Myers Squibb
Size: 5 mL
NDC: 00003-0494-20
UPC: 300030494207
Kenalog 10 (Triamcinolone Acetonide) is a powerful corticosteroid usually administered to treat a variety of medical conditions, including asthma, skin inflammation, ulcerative colitis, arthritis, and certain eye conditions. Kenalog 10 mg is available for injection in a 5 ml multi-dose vial, commonly prescribed for intramuscular injection. Common side effects of Kenalog 10 mg include swelling, redness, irritation, or burning at the site of the injection. As with all medications, it is important to follow the instructions of your doctor carefully and to speak to a doctor about any side effects you may experience. Kenalog 10 mg should be administered carefully and should only be used on the advice of a physician.
- Intra-articular injection: Short-term adjunctive management of acute gouty arthritis, bursitis, tenosynovitis, epicondylitis, rheumatoid arthritis flares, and synovitis of osteoarthritis — administered directly into the affected joint or tendon sheath by a qualified clinician
- Intralesional injection (ILK): Direct injection into dermatologic lesions including keloids, alopecia areata patches, discoid lupus erythematosus, hypertrophic lichen planus plaques, necrobiosis lipoidica diabeticorum, and psoriatic plaques
- Preferred concentration for intralesional use: The 10 mg/mL concentration provides precise dose control at low volumes per injection site, reducing the risk of dermal atrophy compared to higher-concentration formulations
- Professional use only: Must be administered by a licensed healthcare provider using aseptic technique in an appropriate clinical setting
- Buyer types served: Physician offices, outpatient clinics, hospital departments, dermatology and rheumatology practices, EMS agencies, medspas, dental and veterinary practices, and institutional procurement teams
This product is intended for use by qualified healthcare professionals or under the guidance of a licensed medical provider. It is not a substitute for professional medical advice, diagnosis, or treatment.
- Route restriction (critical): For intra-articular or intralesional use ONLY — NOT for intravenous, intramuscular, intraocular, epidural, or intrathecal administration per FDA-approved prescribing information
- Contraindications: Systemic fungal infections; known hypersensitivity to triamcinolone acetonide or benzyl alcohol; active local infection at the intended injection site
- Infection risk: Do not inject into an infected joint or tissue — corticosteroid immunosuppression can facilitate bacterial proliferation and septic arthritis; strict aseptic technique is mandatory
- Diabetic patients: Transient blood glucose elevation (typically 24–72 hours post-injection) may occur; advise patients to monitor blood glucose and adjust insulin management as directed by their physician
- Post-injection flare: Transient pain increase at the injection site within 24–48 hours is a known short-term reaction; it is not a sign of infection or treatment failure and typically resolves without intervention
- Repeat injection limits: Clinical guidelines generally recommend no more than 3 injections per year in the same joint to reduce the risk of cartilage degradation and periarticular tissue atrophy
- Drug interactions: Inform prescribing clinician of all concurrent medications including blood thinners, antidiabetic agents, antifungals, and any live vaccines prior to administration
This product is intended for use by qualified healthcare professionals or under the guidance of a licensed medical provider. It is not a substitute for professional medical advice, diagnosis, or treatment.
For Licensed Healthcare Professionals Only. Kenalog-10 Injection (Triamcinolone Acetonide, 10 mg/mL) is a prescription-only (Rx) pharmaceutical product regulated under US federal law. Purchase is restricted to individuals and entities holding a valid US medical, pharmacy, veterinary, or other applicable professional licence. Mountainside Medical Equipment is not authorised to supply this product to unlicensed individuals.
The clinical and pharmacological information provided on this page is intended as a general reference for qualified healthcare professionals and is based on the FDA-approved prescribing information for Kenalog-10 Injection as published by Bristol Myers Squibb. This content does not constitute medical advice, clinical guidance, or a substitute for the full prescribing information, which should be reviewed in its entirety before clinical use.
All dosing, administration, and clinical usage decisions must be made by a licensed healthcare provider based on the individual patient's clinical presentation, medical history, and current prescribing information. Mountainside Medical Equipment makes no representations regarding patient outcomes.
Product specifications, availability, and pricing are subject to change without notice. For the most current prescribing information, refer to the FDA DailyMed database at dailymed.nlm.nih.gov or contact Bristol Myers Squibb directly.